- Home
- MODV vs MDWD Comparison
MODV vs MDWD Comparison
Compare MODV & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- MDWD
- Stock Information
- Founded
- MODV 1996
- MDWD 2000
- Country
- MODV United States
- MDWD Israel
- Employees
- MODV N/A
- MDWD N/A
- Industry
- MODV Transportation Services
- MDWD Medicinal Chemicals and Botanical Products
- Sector
- MODV Consumer Discretionary
- MDWD Health Care
- Exchange
- MODV Nasdaq
- MDWD Nasdaq
- Market Cap
- MODV 166.7M
- MDWD 184.8M
- IPO Year
- MODV N/A
- MDWD 2014
- Fundamental
- Price
- MODV $5.94
- MDWD $18.42
- Analyst Decision
- MODV Buy
- MDWD Strong Buy
- Analyst Count
- MODV 5
- MDWD 1
- Target Price
- MODV $18.20
- MDWD $25.00
- AVG Volume (30 Days)
- MODV 580.6K
- MDWD 64.8K
- Earning Date
- MODV 02-20-2025
- MDWD 11-26-2024
- Dividend Yield
- MODV N/A
- MDWD N/A
- EPS Growth
- MODV N/A
- MDWD N/A
- EPS
- MODV N/A
- MDWD N/A
- Revenue
- MODV $2,787,619,000.00
- MDWD $19,720,000.00
- Revenue This Year
- MODV $3.92
- MDWD $10.37
- Revenue Next Year
- MODV $6.40
- MDWD $26.36
- P/E Ratio
- MODV N/A
- MDWD N/A
- Revenue Growth
- MODV 3.16
- MDWD N/A
- 52 Week Low
- MODV $5.55
- MDWD $11.04
- 52 Week High
- MODV $52.33
- MDWD $24.00
- Technical
- Relative Strength Index (RSI)
- MODV 28.57
- MDWD 54.95
- Support Level
- MODV $5.55
- MDWD $15.80
- Resistance Level
- MODV $7.84
- MDWD $19.60
- Average True Range (ATR)
- MODV 1.42
- MDWD 1.01
- MACD
- MODV -0.32
- MDWD 0.07
- Stochastic Oscillator
- MODV 5.41
- MDWD 68.95
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.